文献速递瓣膜病与结构性心脏病血脂与心血管预防

经导管主动脉瓣置换术后原发性止血障碍与晚期大出血

Primary Hemostatic Disorders and Late Major Bleeding After Transcatheter Aortic Valve Replacement.
PubMed 文献 · J Am Coll Cardiol · 2018-01-01

本研究纳入372例TAVR术后30天存活患者,评估原发性止血障碍对晚期主要/危及生命出血并发症(MLBCs)的影响。中位随访383天,MLBCs发生率为11.3%,且与全因死亡和心源性死亡风险显著增加相关。CT-ADP>180秒和瓣周漏是MLBCs的强预测因素。

要点

  • TAVR术后晚期MLBCs发生率为11.3%,以消化道出血为主。
  • CT-ADP>180秒者MLBCs风险增加约2.5倍(27.4% vs 11.5%)。
  • 瓣周漏和CT-ADP>180秒是MLBCs的独立预测因素。

核心结论

  • TAVR术后晚期MLBCs常见,且与全因死亡和心源性死亡风险增加相关。
  • 瓣周漏和CT-ADP>180秒是MLBCs的强预测因素。
  • 持续性高分子量血管性血友病因子缺陷可能增加残余瓣周漏患者的出血风险。

研究设计与样本

  • 研究纳入372例TAVR术后30天存活患者,随访中位383天(IQR 188-574天)。
  • 出血事件按VARC-2标准评估,术后24小时测定CT-ADP。
  • 原发性止血障碍定义为CT-ADP>180秒。

主要发现

  • 42例(11.3%)发生MLBCs,主要来源于消化道(42.8%)。
  • MLBCs与全因死亡风险增加相关(HR 5.66;95%CI 3.10-10.31;p<0.001)。
  • MLBCs与心源性死亡风险增加相关(HR 11.62;95%CI 4.59-29.37;p<0.001)。
  • CT-ADP>180秒患者MLBCs发生率为27.4%,显著高于CT-ADP≤180秒者的11.5%(p<0.001)。
  • 多因素回归显示瓣周漏(HR 6.31;95%CI 3.43-11.60;p<0.0001)和CT-ADP>180秒(HR 3.08;95%CI 1.62-5.81;p=0.0005)是MLBCs的预测因素。

临床怎么用

  • TAVR术后应关注晚期出血风险,尤其对于存在瓣周漏或CT-ADP>180秒的患者。
  • CT-ADP可作为评估原发性止血障碍的指标,帮助识别高出血风险患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Periprocedural and late (>30 days) bleedings represent major complications after transcatheter aortic valve replacement and have been identified as potential areas for improved patient care. OBJECTIVES: The authors sought to evaluate the impact of ongoing primary hemostasis disorders on late major/life-threatening bleeding complications (MLBCs). METHODS: Bleedings were assessed according to the VARC-2 (Valve Academic Research Consortium-2) criteria. Closure time of adenosine diphosphate (CT-ADP), a surrogate marker of high molecular weight von Willebrand multimers proteolysis was assessed 24 h after the procedure. Ongoing primary hemostasis disorder was defined by a CT-ADP >180 s. RESULTS: Among 372 patients who survived at 30 days, MLBCs occurred in 42 patients (11.3%) at a median follow-up of 383 days (interquartile range: 188 to 574 days). MLBCs were mainly of gastrointestinal origin (42.8%) and were associated with increased overall mortality (hazard ratio [HR]: 5.66; 95% confidence interval [CI]: 3.10 to 10.31; p < 0.001) and cardiac mortality (HR: 11.62; 95% CI: 4.59 to 29.37; p < 0.001). A 2.5-fold elevation of MLBCs could be evidenced in patients with a CT-ADP > 180 s (27.4% vs. 11.5%; p < 0.001). Multivariate regression analysis identified paravalvular leak (PVL) (HR: 6.31; 95% CI: 3.43 to 11.60; p < 0.0001) and CT-ADP > 180 s (HR: 3.08; 95% CI: 1.62 to 5.81; p = 0.0005) as predictor of MLBCs. CONCLUSIONS: MLBCs after transcatheter aortic valve replacement are frequent and associated with an increased morbidity and mortality. PVL and CT-ADP >180 s were identified as strong predictors for MLBCs. These findings strongly suggest that persistent HMW defects contribute to enhanced bleeding risk in patients with residual PVL.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Kibler M, Marchandot B, Messas N, et al. Primary Hemostatic Disorders and Late Major Bleeding After Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2018. PMID: 30360823. doi:10.1016/j.jacc.2018.08.2143

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。